United Laboratories International Holdings Balance Sheet Health
Financial Health criteria checks 6/6
United Laboratories International Holdings has a total shareholder equity of CN¥13.6B and total debt of CN¥2.4B, which brings its debt-to-equity ratio to 18%. Its total assets and total liabilities are CN¥22.8B and CN¥9.3B respectively. United Laboratories International Holdings's EBIT is CN¥3.4B making its interest coverage ratio -58.1. It has cash and short-term investments of CN¥6.6B.
Key information
18.0%
Debt to equity ratio
CN¥2.44b
Debt
| Interest coverage ratio | -58.1x |
| Cash | CN¥6.55b |
| Equity | CN¥13.57b |
| Total liabilities | CN¥9.25b |
| Total assets | CN¥22.83b |
Recent financial health updates
United Laboratories International Holdings (HKG:3933) Could Easily Take On More Debt
Dec 14
Is United Laboratories International Holdings (HKG:3933) A Risky Investment?
Aug 31United Laboratories International Holdings (HKG:3933) Has A Rock Solid Balance Sheet
Dec 23Is United Laboratories International Holdings (HKG:3933) Using Too Much Debt?
Aug 30These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely
Dec 20
Recent updates
Here's Why We Think United Laboratories International Holdings (HKG:3933) Is Well Worth Watching
Aug 30Improved Earnings Required Before The United Laboratories International Holdings Limited (HKG:3933) Stock's 26% Jump Looks Justified
Feb 29The United Laboratories International Holdings Limited's (HKG:3933) Low P/E No Reason For Excitement
Jan 04United Laboratories International Holdings (HKG:3933) Could Easily Take On More Debt
Dec 14With EPS Growth And More, United Laboratories International Holdings (HKG:3933) Makes An Interesting Case
Nov 26Is United Laboratories International Holdings (HKG:3933) A Risky Investment?
Aug 31Does United Laboratories International Holdings (HKG:3933) Deserve A Spot On Your Watchlist?
Aug 10United Laboratories International Holdings (HKG:3933) Has A Rock Solid Balance Sheet
Dec 23Are Investors Undervaluing The United Laboratories International Holdings Limited (HKG:3933) By 47%?
Oct 19Is United Laboratories International Holdings (HKG:3933) Using Too Much Debt?
Aug 30Is The United Laboratories International Holdings Limited (HKG:3933) A Smart Pick For Income Investors?
Mar 08The United Laboratories International Holdings (HKG:3933) Share Price Is Up 108% And Shareholders Are Boasting About It
Feb 18The United Laboratories International Holdings Limited's (HKG:3933) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Feb 03Did The United Laboratories International Holdings Limited (HKG:3933) Insiders Sell Shares?
Jan 19We Wouldn't Rely On United Laboratories International Holdings's (HKG:3933) Statutory Earnings As A Guide
Jan 04These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely
Dec 20What Type Of Shareholders Own The Most Number of The United Laboratories International Holdings Limited (HKG:3933) Shares?
Dec 07The United Laboratories International Holdings Limited (HKG:3933) Is Yielding 1.3% - But Is It A Buy?
Nov 23Financial Position Analysis
Short Term Liabilities: 3933's short term assets (CN¥15.1B) exceed its short term liabilities (CN¥7.4B).
Long Term Liabilities: 3933's short term assets (CN¥15.1B) exceed its long term liabilities (CN¥1.8B).
Debt to Equity History and Analysis
Debt Level: 3933 has more cash than its total debt.
Reducing Debt: 3933's debt to equity ratio has reduced from 70.1% to 18% over the past 5 years.
Debt Coverage: 3933's debt is well covered by operating cash flow (126.6%).
Interest Coverage: 3933 earns more interest than it pays, so coverage of interest payments is not a concern.